Adrenergic alpha-1 Receptor Antagonists
"Adrenergic alpha-1 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS.
| Descriptor ID |
D058668
|
| MeSH Number(s) |
D27.505.519.625.050.200.100.100 D27.505.696.577.050.200.100.100
|
| Concept/Terms |
Adrenergic alpha-1 Receptor Antagonists- Adrenergic alpha-1 Receptor Antagonists
- Adrenergic alpha 1 Receptor Antagonists
- Adrenergic alpha1-Antagonists
- Adrenergic alpha1 Antagonists
- alpha1-Antagonists, Adrenergic
- alpha-1 Adrenergic Blocking Agents
- alpha 1 Adrenergic Blocking Agents
- alpha1-Adrenoceptor Blocker
- alpha1 Adrenoceptor Blocker
- Adrenergic alpha-1 Antagonists
- Adrenergic alpha 1 Antagonists
- alpha-1 Antagonists, Adrenergic
- Adrenergic alpha-1 Receptor Blockers
- Adrenergic alpha 1 Receptor Blockers
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic alpha-1 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic alpha-1 Receptor Antagonists".
This graph shows the total number of publications written about "Adrenergic alpha-1 Receptor Antagonists" by people in this website by year, and whether "Adrenergic alpha-1 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenergic alpha-1 Receptor Antagonists" by people in Profiles.
-
Doxazosin treatment in cocaine use disorder: pharmacogenetic response based on an alpha-1 adrenoreceptor subtype D genetic variant. Am J Drug Alcohol Abuse. 2020; 46(2):184-193.
-
Are There Effective Psychopharmacologic Treatments for PTSD? J Clin Psychiatry. 2018 12 18; 80(3).
-
Pharmacogenetics of Dopamine ?-Hydroxylase in cocaine dependence therapy with doxazosin. Addict Biol. 2019 05; 24(3):531-538.
-
The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study. J Hum Hypertens. 2016 09; 30(9):549-54.
-
Dacryocystitis and Failure of Dacryocystorhinostomy Associated with Tamsulosin. Ophthalmic Plast Reconstr Surg. 2015 Nov-Dec; 31(6):492.
-
The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):66-70.
-
Noradrenergic a1 receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. PLoS One. 2012; 7(2):e30854.
-
Is there a role for tamsulosin after shock wave lithotripsy in the treatment of renal and ureteral calculi? J Endourol. 2011 Mar; 25(3):495-8.
-
Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol. 2009 Jul 15; 104(2):270-5.
-
Prospective multicenter evaluation of cataract surgery in patients taking tamsulosin (Flomax). Ophthalmology. 2007 May; 114(5):957-64.